2 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Martin Gutierrez: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selinexor Combination Ph 1 Study Selinexor, Irinotecan - Solid Tumor Malignancy | Phase 1 / Phase 2 | Withdrawn | Martin Gutierrez | 2014-09-01 | 2022-01-04 | |
| LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel Docetaxel, Prednisone, LDE225 - Prostate Cancer | Phase 1 | Withdrawn | Martin Gutierrez | 2014-07-01 | 2019-06-19 |
Docetaxel (1) · Irinotecan (1) · Prednisone (1) · selinexor (1) · sonidegib (1)
United States (2)